Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echinochrome is a polyhydroxylated 1,4-naphthoquinone pigment (spinochrome) naturally found in sea urchins. It is the active ingredient in several products including Histochrome and EchA Marine. Echinochrome acts primarily as an antioxidant by scavenging reactive oxygen species (ROS), thereby preventing redox imbalance and cellular damage. It also exhibits anti-inflammatory effects by modulating cytokine production—reducing pro-inflammatory interleukins (such as IL-1B and IL-6) and increasing anti-inflammatory interleukin IL-10 levels[1][4]. Clinically approved in Russia for myocardial infarction and used for ophthalmic diseases under the brand name Histochrome[3][4], it has also been studied as a dietary supplement to improve quality of life in long COVID patients[3][7]. Its pharmacological actions include cardioprotection after myocardial infarction[5], neuroprotection after cerebral ischemia[9], metabolic regulation (glucose/lipid lowering)[1], and general reduction of inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on echinochrome.